A phase II clinical trial of sunitinib following hepatic transarterial embolization for metastatic neuroendocrine tumors von Strosberg, J.R., Weber, J.M., Choi, J., Campos, T.L., Valone, T.L., Han, G., Schell, M.J., Kvols, L.K.

Volltext

A meta-analysis of the accuracy of a neuroendocrine tumor mRNA genomic biomarker (NETest) in blood von Öberg, K., Califano, A., Strosberg, J.R., Ma, S., Pape, U., Bodei, L., Kaltsas, G., Toumpanakis, C., Goldenring, J.R., Frilling, A., Paulson, S.

Volltext

A nonrandom association of gastrointestinal stromal tumor (GIST) and desmoid tumor (deep fibromatosis): case series of 28 patients von Dumont, A.G., Rink, L., Godwin, A.K., Miettinen, M., Joensuu, H., Strosberg, J.R., Gronchi, A., Corless, C.L., Goldstein, D., Rubin, B.P., Maki, R.G., Lazar, A.J., Lev, D., Trent, J.C., von Mehren, M.

Volltext

Phase II clinical trial of pasireotide long-acting repeatable in patients with metastatic neuroendocrine tumors von Cives, M, Kunz, P L, Morse, B, Coppola, D, Schell, M J, Campos, T, Nguyen, P T, Nandoskar, P, Khandelwal, V, Strosberg, J R

Volltext

A phase II study of axitinib in advanced neuroendocrine tumors von Strosberg, J R, Cives, M, Hwang, J, Weber, T, Nickerson, M, Atreya, C E, Venook, A, Kelley, R K, Valone, T, Morse, B, Coppola, D, Bergsland, E K

Volltext

A multi-institutional, phase II open-label study of ganitumab (AMG 479) in advanced carcinoid and pancreatic neuroendocrine tumors von Strosberg, J R, Chan, J A, Ryan, D P, Meyerhardt, J A, Fuchs, C S, Abrams, T, Regan, E, Brady, R, Weber, J, Campos, T, Kvols, L K, Kulke, M H

Volltext

Survival analyses of pancreatic neuroendocrine tumors: Contrasting institutional databases with population-based studies von Strosberg, J. R., Halfdanarson, T. R.

Volltext

Adoption of neuroendocrine tumor (NET) research into treatment guidelines: Are rare cancers neglected? von Strosberg, J. R., Kvols, L. K.

Volltext

Octreotide use in patients with metastatic pancreatic neuroendocrine tumors von Cheema, A., Weber, J., Kvols, L. K., Strosberg, J. R.

Volltext

Risk of metastatic spread in patients with early-stage, surgically resected pancreatic neuroendocrine tumors von Strosberg, J. R., Cheema, A., Weber, J., Kvols, L. K.

Volltext

Prognostic relevance of a novel AJCC staging classification for neuroendocrine tumors of the pancreas von Strosberg, J. R., Cheema, A., Weber, J., Kvols, L. K.

Volltext

Incidental diagnosis of pancreatic neuroendocrine tumors von Cheema, A., Kvols, L. K., Strosberg, J. R.

Volltext

Stage I nonfunctioning neuroendocrine tumors of the pancreas: Surgery or surveillance? von Strosberg, J. R., Cheema, A., Kvols, L. K.

Volltext

Everolimus in patients with advanced pancreatic neuroendocrine tumors (pNET): Updated results of a randomized, double-blind, placebo-controlled, multicenter, phase III trial (RADIA... von Strosberg, J. R., Lincy, J., Winkler, R. E., Wolin, E. M.

Volltext

Phase II study of sunitinib malate following hepatic artery embolization for metastatic neuroendocrine tumors von Strosberg, J. R., Cheema, A., Campos, T., Valone, T., Kvols, L. K.

Volltext

Phase II study of RO4929097 in metastatic colorectal cancer von Valone, T., Yeatman, T. J., Sullivan, D., Kim, R. D., Almhanna, K., Giglia, J. L., Strosberg, J. R.

Volltext

Efficacy of Octreotide LAR (OCT) in Patients (pts) with Advanced Neuroendocrine Tumors (NET): A Subgroup Analysis of Phase III RADIANT-2 Study with Updated Overall Survival (OS) von Strosberg, J. R., Yao, J. C., Bajetta, E., Aout, M., Bakker, B., Hainsworth, J. D., Ruszniewski, P., Cutsem, E. V., Öberg, Kjell, Pavel, M.

Volltext

Metastatic Type 1 Gastric Carcinoid-A Real Threat or Just a Myth? von Glasberg, S., Thomas, D., Strosberg, J. R., Pape, U. F., Felder, S., Tsolakis, Apostolos, Alexandraki, K., Fraenkel, M., Saiegh, L., Reissman, P., Kaltsas, G., Gross, D. J.

Volltext

First-line treatment of metastatic pancreatic endocrine carcinomas with capecitabine and temozolomide von Strosberg, J. R., Choi, J., Gardner, N., Kvols, L.

Volltext

Clinicopathologic analysis of well, moderately and poorly differentiated gastroenteropancreatic neuroendocrine tumors von Strosberg, J. R., Coppola, D., Neumann, A., Kvols, L.

Volltext